Analyst stock forecast
Myriad Genetics Forecast: $3.96 Analyst Target
MYGN has a $3.96 target, Hold rating and 8 analysts. As of 2026-08-18.
Direct answer
Myriad Genetics's average price target is $3.96.
The target implies +29.7% from the recorded current price, and the consensus rating is Hold.
The low target implies -1.6%, the high target implies +78.7%, and the range spans 80.3% of the current price.
Forecast evidence checked August 18, 2026.
Get free Myriad Genetics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.05
- Average price target
- $3.96
- High price target
- $5.45
- Low price target
- $3.00
- Low target gap
- -1.6%
- Target upside
- +29.7%
- High target gap
- +78.7%
- Target range width
- 80.3%
- Consensus rating
- Hold
- Analysts
- 8
- Evidence date
- August 18, 2026
- Valid through
- August 25, 2026
Explore related company data
Read the frequently asked questions.
What is Myriad Genetics's average price target?
Myriad Genetics's verified average price target is $3.96. The target range is $3.00 to $5.45.
How far are Myriad Genetics's low and high targets from the recorded price?
The low target implies -1.6%, while the high target implies +78.7%.
How many analysts are included in Myriad Genetics's consensus?
The verified consensus includes 8 analysts.
How is Myriad Genetics's target upside or downside calculated?
The average target of $3.96 is divided by the recorded price of $3.05, then one is subtracted to produce +29.7%. This does not guarantee a future return.
When was Myriad Genetics's analyst forecast verified?
The data was verified on 2026-08-18. The dataset is valid through 2026-08-25.